Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these https://miriamwybl110296.topbloghub.com/42604388/retatrutide-a-promising-new-treatment-for-obesity